A Multicenter, Randomized Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting from Combined Use of Nestorone Gel (0, 8 or 12 mg NES) and Testosterone Gel (10g) Compared with Testosterone Gel in Normal Men (Protocol CCN007) (Short Title: NES-2).

Trial Profile

A Multicenter, Randomized Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting from Combined Use of Nestorone Gel (0, 8 or 12 mg NES) and Testosterone Gel (10g) Compared with Testosterone Gel in Normal Men (Protocol CCN007) (Short Title: NES-2).

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2014

At a glance

  • Drugs Elcometrine (Primary) ; Testosterone
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms NES-2
  • Most Recent Events

    • 26 Jun 2012 Status changed from active, no longer recruiting to completed.
    • 13 Feb 2011 Actual Initiation Date (1 May 2009 ) added ss reported by ClinicalTrials.gov.
    • 13 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top